Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Tumors in the lung--morphologic features and the challenge of integrating biomarker signatures into diagnostics.

Vollmer E, Schultz H, Stellmacher F, Kähler D, Abdullah M, Galle J, Lang DS, Goldmann T.

Rom J Morphol Embryol. 2010;51(4):607-14. Review.

2.

[Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].

Li F, Zhong Z, Li R, Huang H, Wang L, Zheng D, Zhang D.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):317-21. doi: 10.3779/j.issn.1009-3419.2010.04.09. Chinese.

3.
4.

Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.

Jiang SX, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H.

Am J Surg Pathol. 1998 May;22(5):526-37.

PMID:
9591721
5.

Approach to the diagnosis of neuroendocrine lung neoplasms: variabilities and pitfalls.

Hammar SP.

Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):183-90. Review.

PMID:
17185177
6.

Multidisciplinary approach in diagnosis of lung carcinoma.

Kontic M, Stojsic J, Kacar-Kukric V, Jekic B, Bunjevacki V.

Exp Oncol. 2010 Jul;32(2):111-3.

PMID:
20693974
8.

Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung.

Araki K, Ishii G, Yokose T, Nagai K, Funai K, Kodama K, Nishiwaki Y, Ochiai A.

Lung Cancer. 2003 May;40(2):173-80.

PMID:
12711118
9.

Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.

Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.

Cancer. 2007 Jun 15;109(12):2506-14.

10.

hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.

Jiang SX, Kameya T, Asamura H, Umezawa A, Sato Y, Shinada J, Kawakubo Y, Igarashi T, Nagai K, Okayasu I.

Mod Pathol. 2004 Feb;17(2):222-9.

11.

Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma.

Meyronet D, Massoma P, Thivolet F, Chalabreysse L, Rogemond V, Schlama A, Honnorat J, Thomasset N.

Am J Surg Pathol. 2008 Nov;32(11):1699-708. doi: 10.1097/PAS.0b013e31817dc37c.

PMID:
18769332
12.

Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas.

Schmid K, Angerstein N, Geleff S, Gschwendtner A.

Mod Pathol. 2006 Mar;19(3):453-9.

13.

Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases.

Cassoni P, Daniele L, Maldi E, Righi L, Tavaglione V, Novello S, Volante M, Scagliotti GV, Papotti M.

Histopathology. 2009 Jul;55(1):20-7. doi: 10.1111/j.1365-2559.2009.03326.x.

PMID:
19614763
14.

Epithelial tumors of the lung.

Gould VE, Warren WH.

Chest Surg Clin N Am. 2000 Nov;10(4):709-28. Review.

PMID:
11091921
15.

High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.

Ibe T, Shimizu K, Nakano T, Kakegawa S, Kamiyoshihara M, Nakajima T, Kaira K, Takeyoshi I.

J Surg Oncol. 2010 Jul 1;102(1):11-7. doi: 10.1002/jso.21576.

PMID:
20578072
16.

Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.

Wikman H, Seppänen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-Siukola K, Nagy B, Karjalainen A, Sioris T, Salo J, Hollmén J, Knuutila S, Anttila S.

J Pathol. 2004 May;203(1):584-93.

PMID:
15095482
17.

Differential expression of neural-cadherin in pulmonary epithelial tumours.

Zynger DL, Dimov ND, Ho LC, Laskin WB, Yeldandi AV.

Histopathology. 2008 Feb;52(3):348-54. doi: 10.1111/j.1365-2559.2007.02952.x.

PMID:
18269586
18.

TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.

Rossi G, Marchioni A, Milani M, Scotti R, Foroni M, Cesinaro A, Longo L, Migaldi M, Cavazza A.

Am J Clin Pathol. 2004 Dec;122(6):884-93.

PMID:
15595193
19.

Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.

Sturm N, Lantuéjoul S, Laverrière MH, Papotti M, Brichon PY, Brambilla C, Brambilla E.

Hum Pathol. 2001 Sep;32(9):918-25.

PMID:
11567220
20.

Large cell/neuroendocrine carcinoma.

Gollard R, Jhatakia S, Elliott M, Kosty M.

Lung Cancer. 2010 Jul;69(1):13-8. doi: 10.1016/j.lungcan.2009.12.011. Epub 2010 Feb 4. Review.

PMID:
20133008

Supplemental Content

Support Center